Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01685892
Title A Study of Venetoclax (GDC-0199; ABT-199) in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
UCSD Moores Cancer Center La Jolla California 92093 United States Details
Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center Denver Colorado 80218 United States Details
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10021 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Oncology Associates of Oregon Springfield Oregon 97477 United States Details
SCRI-Tennessee Oncology Nashville Tennessee 37203 United States Details
The Methodist Hospital Research Institute; Academic Office of Clinical Trials Houston Texas 77030 United States Details
St James University Hospital Leeds LS9 7TF United Kingdom Details
Leicester Royal Infirmary NHS Trust Leicester LE1 5WW United Kingdom Details
Barts and The London School of Medicine and Dentistry; Queen Mary, University of London London E1 2AD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field